Effect of Omega3 on serum Visfatin concentratio
Not Applicable
- Conditions
- diabetes.non-insulin-dependent
- Registration Number
- IRCT138903164109N1
- Lead Sponsor
- Tehran Medical Sience University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 71
Inclusion Criteria
type II diabetic women with at least five years past from their diagnosis; women who were volunteers for participating in the study.
Exclusion criteria: insulin injection, secondary complications of diabetes such as ophthalmic and renal complication, amputation, diseases caused by diabetes complications such as kidney disease, amputation, blindness, heart diseases, and inflammatory disease in which CPR level was +++ or more.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visfatin. Timepoint: befor and after trial. Method of measurement: special Lab kit.
- Secondary Outcome Measures
Name Time Method TG. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;HbA1c. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;Cholestrol. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;FBS. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;HDL. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.;LDL. Timepoint: befor and after intervention. Method of measurement: pars azmoon kit.